Skip to main content

Table 2 Crude and adjusted prevalence of SARS-CoV-2 anti-S cases among 2360 participants from eight Egyptian governorates

From: A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population

 

Crude prevalence

Adjusted prevalence

No.

%

Estimate%

95% CI

Governorate

 Alexandria

295

41.3

44.3

38.6–50.0

 Monufia

259

40.7

43.6

37.6–49.5

 Cairo

92

42.2

45.2

35.0–55.4

 Giza

64

49.2

52.7

40.5–64.9

 Qalyubia

77

37.2

39.8

28.9–50.7

 Dakahlia

92

35.8

38.3

28.4–48.2

 Faiyum

67

67.0

71.9

62.9–80.8

 Suez

74

77.9

83.6

76.3–91.1

Gender

 Male

428

39.1

41.9

39.0–44.8

 Female

592

46.8

50.2

47.4–53.0

Age (years)

 < 15

208

45.5

48.8

44.2–53.4

 15–29

183

42.4

45.4

40.7–50.1

 30–39

174

41.9

44.8

40.0–49.6

 40–59

334

43.4

46.5

43.0–50.0

 60+

121

42.3

45.2

39.4–50.9

Residence

 Urban

552

45.7

49.0

46.2–51.8

 Rural

346

39.5

42.3

39.0–45.6

 Slum

122

44.2

47.4

38.5–56.3

Educational level

 Illiterate

435

40.7

43.6

38.9–48.3

 Primary

353

44.8

48.0

42.8–53.2

 Preparatory

299

46.8

50.2

44.5–55.9

 Secondary

648

44.9

48.1

44.3–51.9

 University

625

40.6

43.5

39.6–47.4

Marital status

 Single

820

42.6

45.5

42.2–49.0

 Married

1365

42.5

45.4

42.9–48.1

 Divorced/widow

175

52.0

55.7

48.3–63.1

History of COVID-19 diagnosis#

 No

885

40.6

43.5

41.4–45.6

 Yes

135

74.2

79.6

73.3–85.5

History of PCR-confirmed COVID-19

 No

1001

43.3

46.4

44.3–48.4

 Yes

19

41.3

44.3

29.9–58.7

Overall

 Positive

1020

43.2

46.3

44.2–48.3

  1. #Diagnosis based on any diagnostic means (clinical symptoms—laboratory biochemical and hematological parameters—rapid antigen test–PCR–chest CT)